GUMM - Eliminate the Common Cold Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ellen who wrote (732)	7/30/1999 10:17:00 AM
From: DanZ	Read Replies (2) of 5582

Here's some market data for cough and cold products. post.messages.yahoo.com Given that Zicam is much more effective against the common cold than other products on the list, I believe that Zicam could move to the number 7 or 8 spot next year with sales over $80 million. Publication in a widely respected medical journal is probably needed for Zicam to get enough publicity to meet this goal but I am confident that it will happen soon. My estimate is based on using Zicam to treat the common cold only because that's all that the other products on the list do. If the clinical study currently underway demonstrates that Zicam is an effective preventative, and this is subsequently published in a reputable medical journal, I would increase my sales goal to well over $100 million. No other product on the market today can make that claim and sales could approach the top dog, Tylenol, if Zicam is shown to be an effective prevention for the common cold. Dan

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next